Someone at Receptor Life Sciences in Seattle got the jump on everyone in the cannabis industry and started developing an inhaler containing CBD in a dry powdered format. Imagine medicating with a ...

As cancer is the leading cause of death worldwide, killing nearly 10 million people in 2020, researchers around the world are constantly working to find a treatment for the devasting symptoms, if not ...

Seattle startup Receptor Life Sciences has raised $9.7 million to move its CBD-based therapeutic candidate for acute anxiety through clinical testing. The company is developing a dry powdered form of ...

VANCOUVER, July 10, 2019 /CNW/ - Vapen MJ Ventures (CSE: VAPN) ("Vapen MJ") a fully integrated agricultural technology, services and property management company in the regulated cannabis industry, ...

VANCOUVER, Aug. 27, 2019 /CNW/ - Vapen MJ (OTCQX:VAPNF; CSE: VAPN) ("Vapen MJ") a fully integrated agricultural technology, services and property management company in the regulated cannabis industry, ...

SEATTLE--(BUSINESS WIRE)--Receptor Life Sciences (RLS), a pharmaceutical company developing innovative therapies to address central nervous system disorders, announced the publication of a manuscript ...

Need a little pick-me-up as you go about your busy everyday routine? Sometimes life can become slightly overwhelming. Working, running errands and endless grinding can leave a boatload of anxiety and ...

Inhaled CBD shrinks the size of the highly aggressive, lethal brain tumor glioblastoma in an animal model by reducing the essential support of its microenvironment, researchers report. "We saw a ...

The global cannabidiol, or CBD, market is exploding, with analysts projecting it will hit 22.05 billion by the year 2030. That's nearly 20% of the size of the global soft drinks market even though CBD ...

Studies and data have already confirmed that cannabis use, containing THC, tends to help people reduce or eliminate opioid use, generally for symptom management when cannabis can act as a suitable ...